The targeting nanothin polyelectrolyte shells in system with immobilized bacterial cells for antitumor factor

L H Granicka1, M Borkowska, A Grzeczkowicz

  • 1M. Nałęcz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science, Warsaw, Poland.

Insights

Researchers explored using modified Bacillus subtilis bacteria to target cancer cells. Transferrin-coated bacteria showed a stronger lethal effect on leukemia cells, suggesting potential for novel cancer therapies.

Area of Science:

  • Oncology
  • Biotechnology
  • Microbiology

Background:

  • Current anticancer treatments face challenges with efficiency and tumor cell selectivity.
  • Novel strategies are needed to improve cancer therapy outcomes.
  • Oncolytic agents from microorganisms offer a potential approach for apoptotic cancer therapy.

Purpose of the Study:

  • To evaluate the tumor-targeting efficiency of Bacillus subtilis bacterial cells coated with modified polyelectrolyte shells.
  • To assess the protective effect of shells against host immune response.
  • To enhance tumor-targeting capability using transferrin modification.

Main Methods:

  • Bacillus subtilis cells were coated with unmodified and transferrin-modified polyelectrolyte nanothin shells.
  • In vitro experiments were conducted to evaluate the impact on human leukemia cells.
  • Shell modification involved incorporating transferrin to increase affinity for tumor cells.

Main Results:

  • Bacterial cells coated with modified shells demonstrated a significantly stronger lethal impact on leukemia cells compared to those with unmodified shells.
  • Transferrin incorporation enhanced the targeting and cytotoxic effects of the bacterial agent.
  • The modified shell conformation maintained the functionality of the encapsulated microorganisms.

Conclusions:

  • Transferrin-modified Bacillus subtilis shows enhanced efficacy in targeting and inducing apoptosis in leukemia cells.
  • This approach holds promise for developing targeted anticancer treatments.
  • The modified bacterial system may be applicable for local antitumor therapy.

Related Concept Videos